Discovery, synthesis, and anti-cancer evaluation of 10-Pterostilbene methylamine hydrochloride derivatives as potential COX-2 and Topo I dual inhibitors
Yunhou Huang,Shouchuan Wang,Shaoling Huang,Weigao Pan,XuJian Luo,Peng Luo
DOI: https://doi.org/10.1016/j.molstruc.2024.138363
IF: 3.841
2024-04-27
Journal of Molecular Structure
Abstract:A series of ( E )-N-benzyl-1-(2, 4-dimethoxy-6-(4 methoxystyryl) phenyl) methanamine ( DMPM ) derivatives ( D1 - D25 ) were successfully synthesized in the form of hydrochloride, and characterized by spectroscopic techniques. The structure of D15 was further confirmed by X-ray single crystal diffraction, where D15 existed in the form of a dimer constructed by intermolecular hydrogen bonds between the active hydrogen of –NH 2 + − and Cl − , and the –CH=CH– in the molecule was identified as E configuration. Compounds were evaluated for their anti-cancer properties toward HepG2, Eac-109 and MDA-MB-231 cell lines in vitro. Meanwhile, bioactive compound's toxicity against L02 cell lines were also tested. Sixteen compounds ( D2, D5 - D8, D10, D13, D16 - D23 , and D25 ) exhibited significant cytotoxicity against tested cancer cells with IC 50 values ranging from 4.13 to 36.77 μM/L. Their toxicity toward normal human liver cells was lower than that of Cisplatin. Among them, D10, D20 and D25 showed more potent anti-cancer abilities than others. Especially, D20 manifested anti-cancer effects comparable to Cisplatin on all tested cancer cell lines. SAR revealed that –OCH 2 CH(CH 3 ) 2 or –O(CH 2 ) 3 CH 3 substitution (R 1 ) on the benzene ring of Pterostilbene is key factors in enhancing biological activities, while –OCH 3 , –Cl or –F substitution (R 2 ) on another benzene ring is beneficial for improving anti-cancer abilities, and –OCH 3 may be the most favorable modifying groups for enhancing skeleton's activities. Bioactive compounds displayed excellent inhibitory effects on COX-2 at nanomolar concentrations. D20 (IC 50 (COX-2) = 69.92 nm/L) was identified as the most promising COX-2 inhibitor, meanwhile, it also exhibited significant Topo I inhibitory ability at 20 μM/L. In addition, D20 effectively docked to COX-2 (PDB: 5KIR ) and Topo I protein (PDB: 1TBI ) with affinity of -9.0 and -5.7 kcal/mol, respectively. As a potential COX-2 and Topo I dual inhibitor, D20 induced ROS-mediate mitochondria dysfunction and altered the expression of apoptosis related proteins such as Bcl-2, Bax, Caspase3/9, and P53, leading to significant apoptosis in HepG2 cells. Moreover, D20 markedly up-regulated P21, reduced the level of CDK4 or Cyclin D1, and caused G1 phase arrest on HepG2 cancer cell lines.
chemistry, physical